Literature DB >> 32556067

Implications for Design and Analyses of Oncology Clinical Trials During the COVID-19 Pandemic.

Chaya S Moskowitz1, Katherine S Panageas1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32556067     DOI: 10.1001/jamaoncol.2020.2370

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

Review 1.  Oncology During the COVID-19 Pandemic: a Lockdown Perspective.

Authors:  Danielle Boniface; Gonzalo Tapia-Rico
Journal:  Curr Oncol Rep       Date:  2022-05-27       Impact factor: 5.945

2.  Resilience and ongoing quality care for cancer clinical trials during COVID-19: Experience from a tertiary hospital in Australia.

Authors:  Amy Ives; Tricia Pusztai; Jacqui Keller; Elizabeth Ahern; Bryan Chan; Harry Gasper; David Wyld; Glen Kennedy; Graeme Dickie; Zarnie Lwin; Natasha A Roberts
Journal:  Asia Pac J Clin Oncol       Date:  2021-04-05       Impact factor: 1.926

3.  The influence of delayed treatment due to COVID-19 on patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Xinyu Zhao; Lihui Meng; Mingyue Luo; Weihong Yu; Hanyi Min; Rongping Dai; Adrian Koh; Youxin Chen
Journal:  Ther Adv Chronic Dis       Date:  2021-06-22       Impact factor: 5.091

4.  Suspend or amend? Randomized controlled trial on neuropsychological rehabilitation for epilepsy: A COVID-19 impact.

Authors:  Shivani Sharma; Ashima Nehra; Shivam Pandey; Madhavi Tripathi; Achal Srivastava; M V Padma; Ajay Garg; R M Pandey; Sarat Chandra; Manjari Tripathi
Journal:  Epilepsy Behav Rep       Date:  2021-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.